Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
复制标题
DOI:
10.1084/jem.184.4.1513
复制
发表时间:
1996-10-01
影响因子:
15.3
通讯作者:
Husar, W
中科院分区:
文献类型:
--
作者:
Dowling, P;Shang, GF;Husar, W
Immunohistochemical methods were used to search for Fas receptor/Fas ligand system involvement in multiple sclerosis (MS) white matter brain lesions. We found large numbers of Fas Ligand (Fas-L)-bearing cells present in two acute lesions and 12 of 16 chronic MS lesions, and very few positive cells in non-inflammatory controls. Four of six brains from non-MS neuropathologic conditions associated with inflammation and white matter disease were, however, also positive for Fas-L, Double staining with cell-specific markers revealed that the pattern of ligand-positive cells in chronic MS lesions was complex and composed of several different cell types which were primarily resident glial cells with a small overlay of macrophages. Fas/APO 1 (CD95) receptor expression in MS tissue was also evaluated and marked upregulation of the receptor was found. In addition, Fas receptor was induced, but to a lesser extent, in numerous control brains, The observations that TUNEL-positive dying cells were present in MS lesions and showed excellent co-localization with Fas-L, indicate that the Fas death system may contribute to plaque pathogenesis and could lead to the development of a new category of therapeutic agents for MS.